SDSachi S. Dholakia

Sachi S. Dholakia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sachi S. Dholakia has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Thamboo

    St. Paul's Sinus Centre, Department of Otolaryngology—Head and Neck Surgery University of British Columbia Vancouver British Columbia Canada

    5 shared publications
  • Angela Yang

    Division of Rhinology, Department of Otolaryngology—Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.

    3 shared publications
  • Dayoung Kim

    Division of Rhinology, Department of Otolaryngology—Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.

    3 shared publications
  • Jayakar V. Nayak

    Department of Otolaryngology, Head and Neck Surgery Stanford University School of Medicine Stanford California USA

    3 shared publications
  • Ashoke Khanwalkar

    Division of Rhinology, Department of Otolaryngology—Head and Neck Surgery Stanford University School of Medicine Stanford California U.S.A.

    2 shared publications
  • Jayakar V. Nayak

    Department of Otolaryngology–Head and Neck Surgery Stanford University Stanford CA

    2 shared publications

Latest Publications

  • Inferior Meatus Augmentation Procedure (IMAP) for Treatment of Empty Nose Syndrome

    by Michael T. Chang, Murray Bartho, Dayoung Kim, Esmond F. Tsai, Angela Yang, Sachi S. Dholakia, Ashoke Khanwalkar, Vidya K. Rao, Andrew Thamboo, Matt Lechner, et al.


  • Long‐Term Outcomes of Inferior Meatus Augmentation Procedure to Treat Empty Nose Syndrome

    by Sachi S. Dholakia, Angela Yang, Dayoung Kim, Nicole A. Borchard Ba, Michael T. Chang, Ashoke Khanwalkar, Matt Lechner, Jayakar V. Nayak

    Objectives/Hypothesis: We sought to report the long‐term, symptom‐focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through use of four validated questionnaires: Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q), 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐Item Scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Study Design: Prospective case series.Methods: A single‐center prospective case series was performed for patients diagnosed with ENS who underwent IMAP between July 2017 and February 2020. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12 months postoperatively.Results: Seventeen eligible patients were included. Mean ENS6Q scores were significantly reduced at all postoperative time points (p < .0001, p < .0001, p < .0001, p = .0003). Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1‐year postoperatively (p < .0001, p = .0004, p = .0136, p = .0114, p = .0080, respectively). SNOT‐22 scores were significantly reduced at all time points (p = .0021, p = .0227, p = .0004, and p = .0025). Of the SNOT‐22 subdomains, the sleep subdomain was significantly reduced 1‐year postoperatively (p = .0432). Low baseline GAD‐7 and PHQ‐9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.Conclusion: IMAP via implant of cadaveric rib cartilage provides significant, long‐term improvements in ENS‐specific and general sinonasal symptoms.Level of Evidence: 4 Laryngoscope, 131:E2736–E2741, 2021


  • The empty nose syndrome 6‐item questionnaire (ENS6Q): a diagnostic tool to distinguish empty nose syndrome from primary nasal obstruction

    by Ameen Amanian, Kishore Hari, Al‐Rahim Habib, Sachi S. Dholakia, Jayakar Nayak, Andrew Thamboo


  • Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling

    by Jennifer Malik, Sachi Dholakia, Barak M. Spector, Angela Yang, Dayoung Kim, Nicole A. Borchard Bs, Andrew Thamboo, Kai Zhao, Jayakar V. Nayak

    Background: Empty nose syndrome (ENS) is a controversial upper airway disorder most commonly associated with tissue loss from the inferior turbinates. The inferior meatus augmentation procedure (IMAP) has been shown to effectively reduce ENS symptoms in a durable manner, but the precise mechanisms that may govern this symptomatic improvement remain unknown.Methods: Five patients with ENS who underwent bilateral IMAP via submucosal costal cartilage implant were assessed. Pre‐implant and 6 months post‐implant computed tomography (CT) imaging for each ENS patient was analyzed in a blinded fashion using computational fluid dynamics (CFD) modeling to investigate intrapatient changes in airflow parameters.Results: Following surgery, ENS patients have significantly improved symptoms as indexed by Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q) scoring (pre‐implant: 14.00 ± 4.06 [mean ± standard deviation]; 95% confidence interval [CI], 10.44 to 17.56; post‐implant: 4.8 ± 2.77; 95% CI, 2.37 to 7.23; Cohen's d = 2.64; p = 0.02). Using CFD, a significant shift in nasal airflow patterns was observed, where airflow deviates away from the middle meatus upon hitting the implant (pre‐implant: 67.13% ± 11.14%; 95% CI, 60.22% to 74.04%; post‐implant: 46.18% ± 12.81%; 95% CI, 38.23% to 54.12%; d = 1.74; p < 0.05) toward the inferior meatus (pre‐implant: 30.55% ± 11.29%; 95% CI, 23.55% to 37.55%; post‐implant: 42.59% ± 9.60%; 95% CI, 36.63 to 48.54%; d = 1.14; p < 0.05). No significant changes were found in nasal resistance (pre‐implant: 0.102 ± 0.015; 95% CI, 0.092 to 0.112 Pa*s/mL; post‐implant: 0.105 ± 0.041; 95% CI, 0.081 to 0.130 Pa*s/mL). In addition, the improvement of ENS6Q scoring significantly correlated with percent reduction in aberrant airflow through the middle meatus (R2 = 0.60, p = 0.04).Conclusion: This study supports our prior working hypothesis that disordered vectors of nasal airflow congregate in the middle meatus contribute to ENS symptoms, not nasal resistance. Moreover, these data illuminate a paradoxical, but consistent, restoration of nasal airflow to the inferior meatus following the replacement of turbinate tissue volume in the inferior meatus via IMAP surgery, potentially due to the Coandă effect.


  • The cotton test redistributes nasal airflow in patients with empty nose syndrome

    by Jennifer Malik, Andrew Thamboo, Sachi Dholakia, Nicole A. Borchard Ba, Sam McGhee, Chengyu Li, Kai Zhao, Jayakar V. Nayak

    Background: Empty nose syndrome (ENS) remains a controversial disease primarily associated with inferior turbinate tissue loss. Cotton placement into the inferior meatus often alleviates ENS symptoms within minutes, but the physiologic explanation for this phenomenon is unknown. Computational fluid dynamics (CFD) was employed to evaluate the mechanisms of altered nasal airflow conferred by cotton testing.Methods: Six ENS patients (12 sides) with pre‐existing sinus computed tomography (CT) imaging were enrolled after marked symptomatic improvement (decrease in score on the Empty Nose Syndrome 6‐Item Questionnaire [ENS6Q] of >7 points) with office‐based cotton testing. The fashioned cotton plug was labeled in situ with iohexol contrast spray, and sinus CT was immediately obtained to detect cotton contouring in the inferior meatus. CT imaging from pre‐ and post‐cotton placement was analyzed using comparative CFD techniques.Results: After cotton placement, significant symptomatic improvement and reduced ENS6Q scores (16.8 ± 4.1 to 3.1 ± 2.4; p < 0.001) were recorded. Using CFD, cotton placement produced an expected 21% increase in upper airway resistance (p < 0.05). However, a significant shift in the nasal airflow distribution was also detected, with a transition of airflow vectors away from a middle meatus jetstream (−41%; p < 0.002).Conclusion: Objective CFD assessment confirmed that the cotton test not only increases nasal resistance, but also restores airflow distribution to the inferior meatus in symptomatic ENS patients. These results highlight the potential efficacy of cotton test in ENS patients and further bolster the utility of this tool in identifying appropriate candidates for the inferior meatus augmentation procedure.


  • Open Access

    Intralaryngeal Ectopic Thyroid Tissue

    by Hassan Paknezhad, Sachi S. Dholakia, Edward J. Damrose


  • Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndrome

    by Nicole A. Borchard Ba, Sachi S. Dholakia, Carol H. Yan, David Zarabanda, Andrew Thamboo, Jayakar V. Nayak

    Background: Empty nose syndrome (ENS) is a debilitating condition associated with inferior turbinate tissue loss. Surgical augmentation of the inferior meatus has been proposed to treat ENS, although efficacy data with validated, disease‐specific questionnaires is limited. Instead we evaluated submucosal injection of a transient, resorbable filler into the inferior meatus to favorably alter nasal aerodynamics in ENS patients.Methods: Patients with a history of inferior turbinate reduction, diagnosed with ENS via Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q) and cotton testing, were enrolled and underwent submucosal injection of carboxymethylcellulose/glycerin gel (Prolaryn®) into the inferior meatuses between July 2014 and May 2018. This material likely resorbs over several months. Outcomes included comparisons of preinjection and postinjection symptoms at 1 week, 1 month, and 3 months using the ENS6Q, 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐item scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Results: Fourteen patients underwent injections. Mean ENS6Q scores significantly decreased from baseline at 1 week (20.8 vs 10.5; p < 0.0001), and remained reduced but upward‐trending at 1 month (13.7, p = 0.002) and 3 months (15.5, p > 0.05) following injections. Mean SNOT‐22 scores significantly decreased at 1 week (p = 0.01) and 1 month (p = 0.04), mean GAD‐7 at 1 month (p = 0.02) and 3 months (p = 0.02), and mean PHQ‐9 at 1 week (p = 0.01) and 1 month (p = 0.004) postinjection.Conclusion: Transient, focal airway bulking via submucosal filler injection at sites of inferior turbinate tissue loss markedly benefits ENS patients, suggesting that aberrant nasal aerodynamics from inferior turbinate tissue loss contributes to (potentially reversible) ENS symptoms.